Weight-loss jabs could reduce your risk of drug abuse, seizures and pneumonia, as well as heart attacks and strokes, scientists have found. Last year, research revealed that weight-loss jabs – or ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

Demand for weight-loss medications ... or other medications." The study also confirmed past research findings detailing the drugs' potential to lower the risk of heart attack, stroke and other ...

Drugs like Ozempic and Wegovy — known as glucagon-like peptide-1 receptor agonists, or GLP-1s — have made headlines and surged in popularity for their unique ability to help patients lose weight by ...

They found that those taking the popular weight loss drugs, also known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), had a lower risk of stroke, a heart attack, substance use disorders ...

Use of GLP-1 weight loss ... drugs for people taking them for diabetes compared with those who took other medicines. Reporting in Nature Medicine, they created an Atlas of conditions with a reduced ...

GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.

As evidence has mounted that new diabetes and weight loss drugs ... cut the risk of schizophrenia episodes and seizures. Among the other benefits observed were with reductions in heart attacks ...

after results from a study showed that GLP-1 drugs cut the risk of several heart conditions, kidney diseases and brain ailments. New evidence regarding the additional benefits (besides weight loss ...

Demand for weight-loss medications ... or other medications." The study also confirmed past research findings detailing the drugs' potential to lower the risk of heart attack, stroke and other ...

A new study, the first to catalogue these risks and benefits, confirmed that these drugs are associated with a lower risk of heart attack ... These diabetes and weight loss drugs work by slowing ...